| EMA number | EMEA/H/C/000120 |
| ATC code | J05AB06 |
| Authorisation | 18 March 1997 |
| Withdrawn | 2 April 2002 |
| Revision | - |
The Vitrasert implant is indicated for the local treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS) (See 4.4. Special warnings and special precautions for use).